Listed Funds Trust
Horizon Kinetics Medical ETF
$18.61M
Avg Monthly Net Assets
$17.95M
Total Assets
$203K
Total Liabilities
$17.75M
Net Assets
Horizon Kinetics Medical ETF is an Exchange-Traded Fund in Listed Funds Trust
,
based in Wisconsin,
United States of America.
The fund has one share class
and monthly net assets of $18.61M.
On August 29th, 2024 it reported 36 holdings, the largest
being Eli Lilly & Co (17.1%), AbbVie Inc (7.4%) and US BANK MMDA - USBGFS 7 (6.4%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| Horizon Kinetics Medical ETF | C000239791 | XNAS | MEDX |
Holdings
From latest NPORT-P, filed August 29th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 2seventy bio Inc | Long | Equity-common | US | $67K | 17K | 0.37 |
| AbbVie Inc | Long | Equity-common | US | $1M | 8K | 7.42 |
| Alkermes PLC | Long | Equity-common | IE | $555K | 23K | 3.13 |
| Allogene Therapeutics Inc | Long | Equity-common | US | $45K | 19K | 0.25 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $700K | 3K | 3.94 |
| Amgen Inc | Long | Equity-common | US | $1M | 3K | 5.91 |
| AstraZeneca PLC | Long | Equity-common | GB | $973K | 12K | 5.48 |
| Beam Therapeutics Inc | Long | Equity-common | US | $225K | 10K | 1.27 |
| Bicycle Therapeutics PLC | Long | Equity-common | GB | $291K | 14K | 1.64 |
| Biogen Inc | Long | Equity-common | US | $723K | 3K | 4.07 |
| Bluebird Bio Inc | Long | Equity-common | US | $36K | 36K | 0.20 |
| Bristol-Myers Squibb Co | Long | Equity-common | US | $737K | 18K | 4.15 |
| CRISPR Therapeutics AG | Long | Equity-common | CH | $570K | 11K | 3.21 |
| Editas Medicine Inc | Long | Equity-common | US | $148K | 32K | 0.83 |
| Eli Lilly & Co | Long | Equity-common | US | $3M | 3K | 17.13 |
| Galectin Therapeutics Inc | Long | Equity-common | US | $121K | 54K | 0.68 |
| GE HealthCare Technologies Inc | Long | Equity-common | US | $75K | 960 | 0.42 |
| GSK PLC | Long | Equity-common | GB | $434K | 11K | 2.44 |
| Haleon PLC | Long | Equity-common | GB | $116K | 14K | 0.66 |
| Intellia Therapeutics Inc | Long | Equity-common | US | $322K | 14K | 1.82 |
| Ionis Pharmaceuticals Inc | Long | Equity-common | US | $595K | 12K | 3.35 |
| Johnson & Johnson | Long | Equity-common | US | $746K | 5K | 4.21 |
| Lantern Pharma Inc | Long | Equity-common | US | $134K | 29K | 0.76 |
| Merck & Co Inc | Long | Equity-common | US | $832K | 7K | 4.69 |
| Mural Oncology PLC | Long | Equity-common | IE | $7K | 2K | 0.04 |
| Novartis AG | Long | Equity-common | CH | $1M | 10K | 5.76 |
| Pacific Biosciences of California Inc | Long | Equity-common | US | $16K | 12K | 0.09 |
| Pathos AI Inc | Long | Equity-common | US | $0 | 24K | – |
| Pfizer Inc | Long | Equity-common | US | $725K | 26K | 4.08 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $757K | 720 | 4.26 |
| Replimune Group Inc | Long | Equity-common | US | $130K | 14K | 0.73 |
| Salarius Pharmaceuticals Inc | Long | Equity-common | US | $9K | 4K | 0.05 |
| Sandoz Group AG | Long | Equity-common | CH | $70K | 2K | 0.39 |
| US BANK MMDA - USBGFS 7 | Long | Short-term investment vehicle | US | $1M | 1M | 6.40 |
| Vanda Pharmaceuticals Inc | Long | Equity-common | US | $146K | 26K | 0.82 |
| Viatris Inc | Long | Equity-common | US | $38K | 4K | 0.21 |
Address
Listed Funds Trust
C/O U.S. BANCORP FUND SERVICES LLC
615 East Michigan Street
Milwaukee
Wisconsin
53202
United States of America
Websites
Directors
Pam Conroy
Koji Felton
John L. Jacobs
Transfer Agents
U.S. Bancorp Fund Services LLC
Pricing Services
IHS Markit Ltd.
Thomson Reuters Pricing Service
Bloomberg L.P.
PricingDirect Inc.
Intercontinental Exchange Inc.
Custodians
U.S. Bank National Association
Shareholder Servicing Agents
N/A
Admins
U.S. Bancorp Fund Services LLC
U.S. Bancorp Fund Services, LLC
Brokers
BTIG LLC
FLOW TRADERS U.S. LLC
MISCHLER FINANCIAL GROUP INC.